Thrombophilic factors in Stage V chronic kidney disease patients are largely corrected by renal transplantation

Lidia Ghisdal, Nilufer Broeders, Karl Martin Wissing, J Mbaba Mena, Anne Lemy, Walter Wijns, Oliver Pradier, Vincent Donckier, Judith Racape, Pierre Vereertstraeten, Daniel Abramowicz

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

Background. The aim of our study was to evaluate the prevalence of acquired thrombophilic factors in Stage V chronic kidney disease (CKD) patients according to dialysis modality, the rate of correction of these factors 1 month after renal transplantation and their impact on cardiovascular or thromboembolic events at 1 year.

Methods. Three hundred and ten patients were prospectively screened for seven thrombophilic factors at transplantation; 215 of them were also assayed 1 month after. All the patients received prophylactic acetylsalicylic acid, started before transplantation.

Results. The prevalence of thrombophilic factors was significantly higher in patients under dialysis (n = 289) than in patients not yet on dialysis (n = 21) (74 versus 52.4%; P = 0.03) but was similar in haemodialysis and peritoneal dialysis patients (74.2 versus 73.2%). One month after transplantation, the global prevalence of thrombophilic factors had dropped from 74.4 to 44.7% (P
Conclusion. Acquired thrombophilic factors are highly prevalent among Stage V CKD patients. Most thrombophilic factors are corrected 1 month after transplantation.
Original languageEnglish
Pages (from-to)2700-2705
Number of pages6
JournalNephrology Dialysis Transplantation
Volume26
Issue numberAUG
Publication statusPublished - Aug 2011

Keywords

  • coagulation
  • haemodialysis
  • renal transplantation
  • thrombophilia

Fingerprint

Dive into the research topics of 'Thrombophilic factors in Stage V chronic kidney disease patients are largely corrected by renal transplantation'. Together they form a unique fingerprint.

Cite this